The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury
- PMID: 17361386
- DOI: 10.1007/s00134-007-0585-3
The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury
Abstract
Objective: It is well-established that poly(ADP)ribose-polymerase (PARP) assumes major importance during ischemic brain damage, and the selective PARP-1 inhibitor PJ34 reduced spinal cord damage in murine aortic occlusion-induced ischemia/reperfusion injury. We investigated the effect of the PARP-1 inhibitor INO1001 on aortic-occlusion-related porcine spinal cord injury.
Design and setting: Prospective, randomized, controlled experimental study in an animal laboratory.
Patients and participants: Ten anesthetized, mechanically ventilated, and instrumented pigs.
Interventions: Animals underwent 45 min of thoracic aortic cross-clamping after receiving vehicle (n=5) or intravenous INO1001 (n=5, total dose 4 mg/kg administered both before clamping and during reperfusion). During reperfusion continuous intravenous norepinephrine was incrementally adjusted to maintain blood pressure at or above 80% of the preclamping level. Plasma INO1001 levels were analyzed by HPLC. After 4[Symbol: see text]h of reperfusion spinal cord biopsy samples were analyzed for neuronal damage (hematoxyline-eosine and Nissl staining), expression of the cyclin-dependent kinase inhibitor genes p21 and p27 (immunohistochemistry), and apoptosis (terminal deoxynucleotidyl transferase mediated nick end labeling assay).
Measurements and results: Plasma INO1001 levels were 0.8-2.3 and 0.30-0.76 mM before and after clamping, respectively. While 3-5% of the spinal cord neurons were irreversibly damaged in the INO1001 animals, the neuronal cell injury was three times higher in the control group. Neither p21 and p27 expression nor apoptosis showed any intergroup difference.
Conclusions: The selective PARP-1 inhibitor INO1001 markedly reduced aortic occlusion-induced spinal cord injury. Given the close correlation reported in the literature between morphological damage and impaired spinal cord function, INO1001 may improve spinal cord recovery after thoracic aortic cross-clamping.
Similar articles
-
The parp-1 inhibitor ino-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion.Shock. 2006 Jun;25(6):633-40. doi: 10.1097/01.shk.0000209561.61951.2e. Shock. 2006. PMID: 16721272
-
Effects of intrarenal administration of the calcium antagonist nimodipine during porcine aortic occlusion-induced ischemia/reperfusion injury.Shock. 2008 Jun;29(6):717-23. doi: 10.1097/shk.0b013e318160d6f9. Shock. 2008. PMID: 18091572
-
Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.J Vasc Surg. 2005 Jan;41(1):99-107. doi: 10.1016/j.jvs.2004.10.040. J Vasc Surg. 2005. PMID: 15696051
-
Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury.Crit Care Med. 2008 Jul;36(7):2143-50. doi: 10.1097/CCM.0b013e31817d7912. Crit Care Med. 2008. PMID: 18552697
-
Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping.Intensive Care Med. 2007 Apr;33(4):694-702. doi: 10.1007/s00134-006-0518-6. Epub 2007 Jan 20. Intensive Care Med. 2007. PMID: 17237934
Cited by
-
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.
-
Targeting Parthanatos in Ischemic Stroke.Front Neurol. 2021 May 5;12:662034. doi: 10.3389/fneur.2021.662034. eCollection 2021. Front Neurol. 2021. PMID: 34025565 Free PMC article. Review.
-
Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29. Mol Aspects Med. 2013. PMID: 23370117 Free PMC article. Review.
-
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):1-43. doi: 10.1007/s00210-007-0183-5. Epub 2007 Sep 22. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 18038125 Review.
-
Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?Crit Care. 2010;14(3):147. doi: 10.1186/cc8982. Epub 2010 May 6. Crit Care. 2010. PMID: 20459596 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous